The role of immune checkpoint inhibitors in prostate cancer
Introduction Prostate cancer (PC) is the most commonly diagnosed malignant tumour and the third cause of cancer deaths among men in Europe. The treatment of early-stage PC is very effective and in many cases allows achievement of a complete cure, whereas the treatment of metastatic prostate cancer (...
Main Authors: | Gabriel Surdacki, Aneta Szudy-Szczyrek, Aneta Gorący, Katarzyna Chyl-Surdacka, Marek Hus |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Rural Health
2019-03-01
|
Series: | Annals of Agricultural and Environmental Medicine |
Subjects: | |
Online Access: | http://www.journalssystem.com/aaem/The-role-of-checkpoint-Inhibitors-in-Prostate-cancer,96331,0,2.html |
Similar Items
-
Immune checkpoint inhibitors and prostate cancer: a new frontier?
by: Alessandra Modena, et al.
Published: (2016-04-01) -
Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
by: Vicenç Ruiz de Porras, et al.
Published: (2021-04-01) -
Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
by: Xinyu Yan, et al.
Published: (2018-09-01) -
Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review
by: Yu CW, et al.
Published: (2020-11-01) -
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data
by: Simona Duranti, et al.
Published: (2021-04-01)